| abstract |
The invention is concerned with compounds of general formula (I) wherein: A signifies A?1, A2, A3, A4, A5, A6, A7 or A8¿; n signifies 0-2; B signifies B?1, B2 or B3; R1, R2 and R3¿ each independently signify hydrogen, amino, nitro, halogen, lower-alkyl or lower-alkoxy; R?4, R5 and R6¿ each independently signify hydrogen, nitro, halogen, lower-alkyl, lower-alkoxy, cyano, trifluoromethyl, amino, lower-alkylamino or di-lower-alkylamino; R?7, R8 and R9¿ each independently signify hydrogen, amino or nitro, as well as pharmaceutically acceptable salts of compounds of formula (I). These compounds can be used in the control of psychotic disorders which are caused by damage to the dopamine system. |